SLNO
Soleno Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website oleno.life
- Employees(FY) 25
- ISIN US8342033094
Performance
-5.3%
1W
-17.0%
1M
-2.87%
3M
+3.93%
6M
+17.64%
YTD
+33.38%
1Y
Profile
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
Technical Analysis of SLNO 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-27 09:02
High Growth Tech Stocks to Watch in November 2024(Simply Wall St.)
- 2024-11-27 08:00
- 2024-11-27 05:38
Kronos, Idorsia plan layoffs; PTC shelves ALS drug(BioPharma Dive)
- 2024-11-26 19:00
- 2024-11-26 18:40
FDA delays decision of Solenos Prader-Willi syndrome drug(Yahoo Finance)
- 2024-11-26 10:08
- 2024-11-26 09:03
- 2024-11-26 08:30
- 2024-11-25 19:30
- 2024-11-14 16:05
- 2024-11-14 03:05
- 2024-11-12 05:38
- 2024-11-06 16:05
- 2024-10-28 08:00
- 2024-10-27 20:00
- 2024-10-25 14:44
- 2024-10-21 08:00
- 2024-10-20 20:00
- 2024-10-18 18:41
- 2024-10-16 08:44
- 2024-10-15 18:10
- 2024-10-10 19:04
- 2024-10-09 09:33
- 2024-10-08 18:29
- 2024-10-08 09:12
- 2024-10-08 08:30
- 2024-10-07 20:30
- 2024-10-04 06:59
Daily – Vickers Top Buyers & Sellers for 10/04/2024(Argus Research)
- 2024-10-03 17:57
- 2024-10-03 13:03
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.